Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasinumab in Osteoarthritis of the Knee
NCT01239017Phase 2Withdrawn
- Sponsor
- Regeneron Pharmaceuticals
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of fasinumab in osteoarthritis (OA), sponsored by Regeneron Pharmaceuticals. Status: withdrawn.
02
Drugs
fasinumab
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01239017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01239017.